(Q38982777)

8 September 2017

title

IgG1 anti-epidermal growth factor receptor antibodies induce CD8-dependent antitumor activity (English)

1 reference

8 September 2017

5

1 reference

8 September 2017

Jan Kubach

1

1 reference

8 September 2017

Mario Hubo

series ordinal

2

1 reference

8 September 2017

Christiane Amendt

series ordinal

3

1 reference

8 September 2017

Christopher Stroh

series ordinal

4

1 reference

8 September 2017

language of work or name

English

0 references

publication date

26 June 2014

1 reference

International Journal of Cancer

8 September 2017

published in

1 reference

8 September 2017

volume

136

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

821-830

1 reference

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

8 September 2017

cites work

1 reference

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

21 January 2018

1 reference

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

21 January 2018

1 reference

Genetic prognostic and predictive markers in colorectal cancer

21 January 2018

1 reference

Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.

21 January 2018

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

The adaptive immunologic microenvironment in colorectal cancer: a novel perspective

21 January 2018

1 reference

Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel

21 January 2018

1 reference

Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.

21 January 2018

1 reference

Rituximab: mechanism of action

21 January 2018

1 reference

The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma

21 January 2018

1 reference

Humanized mice in translational biomedical research

21 January 2018

1 reference

Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo

21 January 2018

1 reference

Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model

21 January 2018

1 reference

Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.

21 January 2018

1 reference

Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function

21 January 2018

1 reference

Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells.

21 January 2018

1 reference

Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells.

21 January 2018

1 reference

Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells

21 January 2018

1 reference

Sequential metastases of colorectal cancer: Immunophenotypes and spatial distributions of infiltrating immune cells in relation to time and treatments

21 January 2018

1 reference

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines

21 January 2018

1 reference

Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab

21 January 2018

1 reference

Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells

21 January 2018

1 reference

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

21 January 2018

1 reference

In vivo assay of human NK-dependent ADCC using NOD/SCID/gammac(null) (NOG) mice

21 January 2018

1 reference

Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity

21 January 2018

1 reference

Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

21 January 2018

1 reference

Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity

21 January 2018

1 reference

21 January 2018

1 reference

Fcgamma receptors: old friends and new family members

21 January 2018

1 reference

Monoclonal antibody mechanisms of action in cancer.

21 January 2018

1 reference

Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density

21 January 2018

1 reference

Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function

21 January 2018

1 reference

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29037

1 reference

release_ovq7lvhagbhy3fem2i7d2nek5u

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ovq7lvhagbhy3fem2i7d2nek5u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference